Join the Prosthetic Heart Valves group to help and get support from people like you.
Prosthetic Heart Valves News
Related terms: Aortic Valve Replacement, Mitral Valve Replacement, Tricuspid Valve Replacement, Pulmonary Valve Replacement, Heart Valve Replacement
Updated Guidelines Issued for Assessing Prosthetic Heart Valves
TUESDAY, Jan. 16, 2024 – In guidelines issued by the American Society of Echocardiography and published online in the January issue of the Journal of the American Society of Echocardiography,...
Warfarin Cuts Mortality, Thromboembolism After Valve Replacement
THURSDAY, Jan. 4, 2024 – Warfarin use after bioprosthetic surgical aortic valve replacement (sAVR) is associated with lower all-cause mortality and a decreased risk for thromboembolism compared with...
TCT: TAVR, SAVR Comparable for Severe Aortic Stenosis, Small Aortic Annulus
FRIDAY, Oct. 27, 2023 – For patients with severe aortic stenosis (AS) and small aortic annulus (SAA), valve hemodynamic results are comparable with use of transcatheter aortic valve replacement...
Less Than One in Three Patients Participates in Cardiac Rehab Following TAVR
MONDAY, Oct. 16, 2023 – Less than one-third of patients who undergo transcatheter aortic valve replacement (TAVR) appear to participate in cardiac rehabilitation (CR) within 90 days of discharge,...
Most Who Get Heart Valve Replacement Don't Get Follow-Up Rehab
TUESDAY, Oct. 10, 2023 – A majority of people who have a minimally invasive heart valve replacement procedure are not getting the recommended cardiac rehab after their surgeries, researchers say. A...
FDA Medwatch Alert: Pradaxa (dabigatran etexilate mesylate): Drug Safety Communication - Should Not Be Used in Patients with Mechanical Prosthetic Heart Valves
ISSUE: The U.S. Food and Drug Administration (FDA) is informing health care professionals and the public that the blood thinner (anticoagulant) Pradaxa (dabigatran etexilate mesylate) should not be...
Ask a question
To post your own question to this support group, sign in or create an account.